Tavotek realizes that collaboration to leverage the best resources and technology of external partners is vital. 
The first among these efforts was our strategic research alliance formed in 2020 with YiSheng BioPharma. Yisheng is in the business of discovering, developing, and commercializing biotherapeutics for cancer and infectious diseases using its novel PIKA® immunomodulating technology. 

We are actively seeking external partnerships and collaborations with other biotech companies, academic centers, and research institutes worldwide.